Friday, March 27, 2015 7:10:11 PM
Share Structure
Market Value1 .....................$557,426 a/o Mar 26, 2015
Shares Outstanding .....................464,522,000 a/o Dec 31, 2014
Float .............................329,885,864 a/o Dec 31, 2014
Authorized Shares....................... 950,000,000 a/o Dec 31, 2014
Par Value 0.001
Manzo Pharmaceuticals, LLC. is a specialty pharmaceutical company that is developing a range of innovative and affordable formulations for various drugs and supplements. Manzo Pharmaceuticals is focused on addressing the unmet medical needs of patients with innovative, patient-friendly and affordable solutions. Manzo Pharmaceuticals is currently engaged in research and development of a patented new experimental product that will help people with lactose intolerance by removing the symptoms for months at a time after taking it only for a short time. Other products include a safe and natural solution for babies with colic, gas, and stomach discomfort that will be released for sale to the public very shortly.
http://www.otcmarkets.com/stock/MNZO/profile
http://manzopharma.com/
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM